نتایج جستجو برای: mybpc3

تعداد نتایج: 307  

Journal: :Revista espanola de cardiologia 2007
Pablo García-Pavía Javier Segovia Jesús Molano Roberto Mora Frederic Kontny Knut Erik Berge Trond P Leren Luis Alonso-Pulpón

Hypertrophic cardiomyopathy is an autosomal dominant inherited disease characterized by ventricular hypertrophy and myofibril disarray. Mutations responsible for hypertrophic cardiomyopathy have been identified in 11 genes that encode for cardiac sarcomere proteins. Traditionally, hypertrophic cardiomyopathy due to mutation of the myosin-binding protein C gene (MYBPC3) has been thought to follo...

2016
Marisa Ojala Chandra Prajapati Risto-Pekka Pölönen Kristiina Rajala Mari Pekkanen-Mattila Jyrki Rasku Kim Larsson Katriina Aalto-Setälä

Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease, which affects the structure of heart muscle tissue. The clinical symptoms include arrhythmias, progressive heart failure, and even sudden cardiac death but the mutation carrier can also be totally asymptomatic. To date, over 1400 mutations have been linked to HCM, mostly in genes encoding for sarcomeric proteins. However, the patho...

زمینه و هدف: کاردیومیوپاتی هایپرتروفی یک نوع بسیار رایج از بیماری های قلبی با وراثت مندلی است و دلیل رایج مرگ های ناگهانی قلبی در افراد جوان تر از 35 سال می باشد. در بیش از 50% از موارد HCM علت بیماری جهش های ژنی شناسایی شده است. جهش در ژن MYBPC3 (که کد کننده پروتئین C متصل شونده به میوزین قلبی است)، عامل حدود 40% از موارد بالینی HCM است. این مطالعه با هدف بررسی احتمال وجود جهش در اگزون های 30...

Journal: :Revista espanola de cardiologia 2009
Mónica García-Castro Eliecer Coto Julián R Reguero José R Berrazueta Victoria Alvarez Belén Alonso Rocío Sainz María Martín Cesar Morís

INTRODUCTION AND OBJECTIVES Mutation of a sarcomeric gene is the most frequent cause of hypertrophic cardiomyopathy. For each such gene, however, previous studies have reported a range of different mutation frequencies, and clinical manifestations have been highly heterogeneous, both of which limit the use of genetic information in clinical practice. Our aim was to determine the frequency of mu...

2015
Thomas L. Lynch Mayandi Sivaguru Murugesan Velayutham Arturo J. Cardounel Michelle Michels David Barefield Suresh Govindan Cristobal dos Remedios Jolanda van der Velden Sakthivel Sadayappan

Cardiomyopathies can result from mutations in genes encoding sarcomere proteins including MYBPC3, which encodes cardiac myosin binding protein-C (cMyBP-C). However, whether oxidative stress is augmented due to contractile dysfunction and cardiomyocyte damage in MYBPC3-mutated cardiomyopathies has not been elucidated. To determine whether oxidative stress markers were elevated in MYBPC3-mutated ...

Journal: :Circulation. Cardiovascular genetics 2012
Stephen P Page Stavros Kounas Petros Syrris Michael Christiansen Rune Frank-Hansen Paal Skytt Andersen Perry M Elliott William J McKenna

BACKGROUND Small selected cohort studies suggest that mutations in the cardiac myosin binding protein-C (MYBPC3) gene cause late-onset, clinically benign hypertrophic cardiomyopathy (HCM). The aim of this study was to test this hypothesis in a large series of families with HCM associated with MYBPC3 mutations. METHODS AND RESULTS The initial study population comprised 57 probands with 42 muta...

2016
Beatriz Piva e Mattos Fernando Luís Scolari Marco Antonio Rodrigues Torres Laura Simon Valéria Centeno de Freitas Roberto Giugliani Úrsula Matte

Background: Mutations in sarcomeric genes are found in 60-70% of individuals with familial forms of hypertrophic cardiomyopathy (HCM). However, this estimate refers to northern hemisphere populations. The molecular-genetic profile of HCM has been subject of few investigations in Brazil, particularly in the south of the country. Objective: To investigate mutations in the sarcomeric genes MYH7,...

2016
Gabriella Captur Carolyn Y. Ho Saskia Schlossarek Janet Kerwin Mariana Mirabel Robert Wilson Stefania Rosmini Chinwe Obianyo Patricia Reant Paul Bassett Andrew C. Cook Susan Lindsay William J. McKenna Kevin Mills Perry M. Elliott Timothy J. Mohun Lucie Carrier James C. Moon

Hypertrophic cardiomyopathy (HCM) is caused by mutations in sarcomeric proteins, the commonest being MYBPC3 encoding myosin-binding protein C. It is characterised by left ventricular hypertrophy but there is an important pre-hypertrophic phenotype with features including crypts, abnormal mitral leaflets and trabeculae. We investigated these during mouse cardiac development using high-resolution...

2012
Cho-Kai Wu Yin-Tsen Huang Jen-Kuang Lee Liang-Ting Chiang Fu-Tien Chiang Shu-Wei Huang Jiunn-Lee Lin Chuen-Den Tseng Yau-Hung Chen Chia-Ti Tsai

OBJECTIVE Myosin binding protein C (MYBPC3) plays a role in ventricular relaxation. The aim of the study was to investigate the association between cardiac myosin binding protein C (MYBPC3) gene polymorphisms and diastolic heart failure (DHF) in a human case-control study. METHODS A total of 352 participants of 1752 consecutive patients from the National Taiwan University Hospital and its aff...

Journal: :Arquivos brasileiros de cardiologia 2010
Júlia Daher Carneiro Marsiglia Maria do Carmo Pimentel Batitucci Flávia de Paula Clara Barbirato Edmundo Arteaga Aloir Queiroz de Araújo

BACKGROUND Hypertrophic cardiomyopathy (HC) is the most frequent cardiac hereditary disease, caused by mutations in sarcomere protein coding genes. Although more than 430 mutations have been identified in several continents and countries, there have been no reports of mutations in Brazil. OBJECTIVE To carry out a genetic study to identify genetic mutations that cause HC in a group of patients...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید